Ipilimumab

Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer

Boris Sepesi, Nicolas Zhou, William N. William, Heather Lin, Cheuk Hong Leung, Annikka Weissferdt, K. G. Mitchell, Apar Pataer, Garrett L. Walsh, David C. Rice, Jack A. Roth, Reza J. Mehran, Wayne L. Hofstetter, Mara B. Antonoff, Ravi Rajaram, Marcelo V. Negrão, Anne S. Tsao, Don L. Gibbons, John V. Heymach, Ara A. Vaporciyan, Stephen G. Swisher, Tina Cascone

Citations: 94 • 2022

OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study

Boris Sepesi, Tina Cascone, William N. William, Heather Lin, Chun-Yuet Janice Leung, A. Weissferdt, G. Walsh, David C. Rice, Jack A. Roth, Reza J. Mehran, Wayne L. Hofstetter, Mara B. Antonoff, Frank V. Fossella, Frank E. Mott, Xiuning Le, Ferdinandos Skoulidis, J. Zhang, Lauren A. Byers, Vincent K. Lam, Bonnie S. Glisson, Jonathan M. Kurie, George Blumenschein, Anne S. Tsao, Charles Lu, Mehmet Altan, Yasir Y. Elamin, Don L. Gibbons, Vassiliki A. Papadimitrakopoulou, J. Lee, John V. Heymach, Ara A. Vaporciyan, Stephen G. Swisher

Citations: 28 • 2019

Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : prise en charge du cancer du rein

Karim Bensalah, Pierre Bigot, Laurence Albigès, Jean‐Christophe Bernhard, Thomas Bodin, R. Boissier, Jean-Michel Corréas, P. Gimel, Jean François Hetet, Jean‐Alexandre Long, F. Nouhaud, Idir Ouzaïd, Arnaud Méjean

Citations: 24 • 2020

Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study

Wesley Yip, Alireza Ghoreifi, Thomas Gerald, Randall Lee, Jeffrey Howard, Aeen Asghar, Abhinav Khanna, Jie Cai, Manju Aron, Inderbir S. Gill, R. Houston Thompson, Robert G. Uzzo, Vitaly Margulis, Nirmish Singla, Hooman Djaladat

Citations: 23 • 2023

Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer

Hope Feldman, Boris Sepesi, Cheuk Hong Leung, Heather Lin, Annikka Weissferdt, Apar Pataer, William N. William, Garrett L. Walsh, David C. Rice, Jack A. Roth, Reza J. Mehran, Wayne L. Hofstetter, Mara B. Antonoff, Ravi Rajaram, Don L. Gibbons, John V. Heymach, Ara A. Vaporciyan, Stephen G. Swisher, Tina Cascone

Citations: 19 • 2023

Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma

Melissa A. Reimers, R. Sherburne Figenshau, Eric H. Kim, Julie Tucker, Nicole Kasten, Adeel Khan, Jan M. Hanneken, Zachary L. Smith, James J. Hsieh

Citations: 19 • 2020

A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

Heather L. McArthur, Elizabeth Comen, Yolanda Bryce, Stephen B. Solomon, J.H.S. Leal, Micaela Rodine, Christina DiLauro Abaya, Sujata Patil, David B. Page, Larry Norton

Citations: 2 • 2019